SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-23-001753
Filing Date
2023-02-13
Accepted
2023-02-13 08:10:50
Documents
16
Period of Report
2023-02-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K maia-8k_20230213.htm   iXBRL 8-K 44231
2 EX-99.1 maia-ex991_6.htm EX-99.1 23857
3 GRAPHIC g1t330gufqjp000001.jpg GRAPHIC 31144
4 GRAPHIC g1t330gufqjp000004.jpg GRAPHIC 32280
5 GRAPHIC g1t330gufqjp000002.jpg GRAPHIC 141593
  Complete submission text file 0001564590-23-001753.txt   489236

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA maia-20230213.xsd EX-101.SCH 5585
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE maia-20230213_lab.xml EX-101.LAB 20224
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE maia-20230213_pre.xml EX-101.PRE 11990
10 EXTRACTED XBRL INSTANCE DOCUMENT maia-8k_20230213_htm.xml XML 3697
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 23614820
SIC: 2834 Pharmaceutical Preparations